Long-term efficacy and safety results (60 weeks) of a double-blind, placebo-controlled, crossover trial of infliximab for patients with moderate to severe hidradenitis suppurativa

• Book ID: 116585011
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 41 KB
• Volume: 60
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2008.11.472